Journal of Shanghai Jiao Tong University (Medical Science) >
Effects of Escherichia coli outer membrane vesicles on proliferation of breast cancer cells and tumor growth of tumor-bearing mice
Received date: 2022-12-08
Accepted date: 2023-06-01
Online published: 2023-10-28
Objective ·To analyze the effect of Escherichia coli outer membrane vesicle (E.coli-OMV) on the proliferation of 4T1 breast cancer cells in vitro and the inhibition of tumor growth in BALB/c-4T1 tumor-bearing mice in vivo. Methods ·OMVs were collected from the culture supernatant of E.coli and characterized. The uptake of E.coli-OMV by 4T1 cells was detected by fluorescent label tracking method. The effect of E.coli-OMV on 4T1 cell proliferation was detected by CCK-8 method. The effect of E.coli-OMV on 4T1 cell cycle was detected by flow cytometry. The BALB/c-4T1 tumor-bearing mouse models were established by subcutaneous inoculation, and the mice were divided into E.coli-OMV group and Control group, with 10 mice in each group. The mice in the E.coli-OMV group were injected with 0.25 mg/kg E.coli-OMV every 2 d, while the mice in the Control group were injected with equal doses of PBS. The changes in body weight, 40 d survival rate, tumor volume and tumor weight of the two groups of tumor-bearing mice were observed. The pathological morphology of the tumor tissues was evaluated by hematoxylin-eosin staining (H-E staining). The expression of proliferating cell nuclear antigen (PCNA) and CyclinD1 in tumor tissues was observed by immunohistochemical staining. Results ·E.coli-OMVwas spherical membrane vesicle structure with a particle size of (216.00±18.30) nm, which expressed E.coli outer membrane protein A (OmpA) and OmpC. Fluorescence microscopy results showed that 4T1 cells could intake E.coli-OMV. CCK-8 results showed that the inhibitory effect of E.coli-OMV on 4T1 cells was positively correlated with time-dose. Flow cytometry results showed that E.coli-OMV arrested the growth cycle of 4T1 cells in G0/G1 phase. In vivo experiments showed that compared with the Control group, body weight of mice in the E.coli-OMV group decreased slightly after the initial injection (P=0.031), and then recovered, while 40 d survival rate increased (P=0.037). The growth of tumor volume and weight of mice in E.coli-OMV group were lower than those in the Control group (P=0.041, P=0.004). Its tumor volume inhibition rate reached 29.69%, and tumor weight inhibition rate reached 49.81%. The results of H-E staining showed that nuclear splitting images of tumor tissues of mice in the E.coli-OMV group decreased compared to the Control group (P=0.038). The results of immunohistochemical staining showed that the positive expression of PCNA and CyclinD1 in the tumor tissues of mice in the E.coli-OMV group decreased compared to the Control group (P=0.031, P=0.002). Conclusion ·Both in vitro and in vivo studies show that E.coli-OMV can significantly inhibit the proliferation of 4T1 cells.
Lanxi WANG , Guanrong MA , Yongzhu JIANG , Xiulin CHANG , Liaoqiong FANG , Jin BAI . Effects of Escherichia coli outer membrane vesicles on proliferation of breast cancer cells and tumor growth of tumor-bearing mice[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023 , 43(10) : 1245 -1254 . DOI: 10.3969/j.issn.1674-8115.2023.10.004
1 | KATSURA C, OGUNMWONYI I, KANKAM H K, et al. Breast cancer: presentation, investigation and management[J]. Br J Hosp Med (Lond), 2022, 83(2): 1-7. |
2 | AKRAM M, IQBAL M, DANIYAL M, et al. Awareness and current knowledge of breast cancer[J]. Biol Res, 2017, 50(1): 33. |
3 | LIANG S Y, WANG C, SHAO Y C, et al. Recent advances in bacteria-mediated cancer therapy[J]. Front Bioeng Biotechnol, 2022, 10: 1026248. |
4 | FISUSI F A, AKALA E O. Drug combinations in breast cancer therapy[J]. Pharm Nanotechnol, 2019, 7(1): 3-23. |
5 | SONG S, VUAI M S, ZHONG M. The role of bacteria in cancer therapy: enemies in the past, but allies at present[J]. Infect Agent Cancer, 2018, 13: 9. |
6 | 王敏, 苏乌云. 治疗癌症的新型武器: 细菌[J]. 世界最新医学信息文摘(连续型电子期刊), 2019, 19(66): 102-103, 105. |
6 | WANG M, SU W Y, et al. Bacteria: a new weapon against cancer[J]. World Latest Medicine Information, 2019, 19(66): 102-103, 105. |
7 | SEDIGHI M, ZAHEDI BIALVAEI A, HAMBLIN M R, et al. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities[J]. Cancer Med, 2019, 8(6): 3167-3181. |
8 | KIKUCHI Y, OBANA N, TOYOFUKU M, et al. Diversity of physical properties of bacterial extracellular membrane vesicles revealed through atomic force microscopy phase imaging[J]. Nanoscale, 2020, 12(14): 7950-7959. |
9 | 邱晓涵, 李泳江, 吴军勇, 等. 细菌外膜囊泡: 疾病治疗的新途径[J]. 药学学报, 2021, 56(12): 3441-3450. |
9 | QIU X H, LI Y J, WU J Y, et al. Bacterial outer membrane vesicles: a new approach to diseases therapy[J]. Acta Pharmaceutica Sinica, 2021, 56(12): 3441-3450. |
10 | CHEN Q, BAI H Z, WU W T, et al. Bioengineering bacterial vesicle-coated polymeric nanomedicine for enhanced cancer immunotherapy and metastasis prevention[J]. Nano Lett, 2020, 20(1): 11-21. |
11 | CHEN Y, LIU L G, FU H, et al. Comparative proteomic analysis of outer membrane vesicles from Shigella flexneri under different culture conditions[J]. Biochem Biophys Res Commun, 2014, 453(4): 696-702. |
12 | TOYOFUKU M, NOMURA N, EBERL L. Types and origins of bacterial membrane vesicles[J]. Nat Rev Microbiol, 2019, 17(1): 13-24. |
13 | RUDNICKA M, NOSZCZY?SKA M, MALICKA M, et al. Outer membrane vesicles as mediators of plant-bacterial interactions[J]. Front Microbiol, 2022, 13: 902181. |
14 | 胡慧冰, 侯昕宇, 贺牧野, 等. 细菌外膜囊泡包覆的载药纳米粒的制备及其小鼠鼻腔免疫效果评价[J]. 上海交通大学学报(医学版), 2018, 38(2): 155-160. |
14 | HU H B, HOU X Y, HE M Y, et al. Preparation of bacterial outer membrane vesicle coated nanoparticle loaded with drug and evaluation of its nasal immune effect in mice[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2018, 38(2): 155-160. |
15 | YAGHOUBI A, KHAZAEI M, HASANIAN S, et al. Bacteriotherapy in breast cancer[J]. Int J Mol Sci, 2019, 20(23): 5880. |
16 | FARKAS-HIMSLEY H, CHEUNG R. Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia[J]. Cancer Res, 1976, 36(10): 3561-3567. |
17 | STRZALKA W, ZIEMIENOWICZ A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation[J]. Ann Bot, 2011, 107(7): 1127-1140. |
18 | GOLIAS C H, CHARALABOPOULOS A, CHARALABOPOULOS K. Cell proliferation and cell cycle control: a mini review[J]. Int J Clin Pract, 2004, 58(12): 1134-1141. |
/
〈 |
|
〉 |